Canada Pharmaceuticals & Healthcare Q2 2020
Pharmaceutical revenues face an increasingly challenging outlook in Canada over the coming years as a result of aconcerted focus on reducing patented medicine prices. We have revised downward our 10-year pharmaceutical market forecast toreflect recent medicine price regulation changes and might revise it further once the details of the single-payer Pharmacareprogramme become clearer over the coming quarters. Despite this current lack of details, we anticipate continued steps towardsthe implementation of a single-payer prescription medicine coverage programme, which will put additional pressure on medicineprices. Even if Pharmacare is implemented, Canada will remain a major global market in terms of pharmaceutical market size, whiledemand for chronic disease treatment will continue to increase.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook